Delivery Order SPE2DB24D2101-SPE2DB24FKGUG

Award Date 9/24/24
Potential Completion Date 10/16/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceuticals, including the drug TAGRISSO 40 MG TABLET 30S. The $21,016.64 contract is a firm fixed price delivery order awarded on June 7, 2024 with an ultimate completion date of July 1, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and acquisition services to the U.S. Armed Forces. Amerisourcebergen also...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription drug TAGRISSO 80 MG TABLET 30S to the Defense Logistics Agency (DLA). The $21,077.60 firm fixed price delivery order has an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product TAGRISSO 80 MG TABLET 30S to the Medical Supply Chain, a part of the Defense agency. The $21,077.60 firm fixed-price delivery order contract has a completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these prescription drugs to support the Department of Defense's medical treatment programs and facilities worldwide....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,970,017 units of the pharmaceutical drug TAGRISSO 40 MG TABLET 30S. The contract has a ceiling value of $10,508.31 and a period of performance through April 4, 2024. This award is under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $21,016.64, is for the delivery of TAGRISSO 40 MG TABLET 30S to the Department of Defense's Medical Supply Chain. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $21,077.60 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to supply the pharmaceutical product TAGRISSO 80 MG TABLET 30S. The award has an ultimate completion date of June 11, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,538.79 firm-fixed-price contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a completion date of October 9, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,903.03 for the supply of TAGRISSO 80 MG TABLET 30S. The contract was awarded by the Defense Logistics Agency (DLA) on December 20, 2024, with a completion date of January 14, 2025. The contract has a firm fixed price pricing type and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The $10,247.06 firm-fixed-price delivery order has a completion date of June 7, 2023 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TAGRISSO 80 MG TABLET 30S. The contract has a ceiling value of $10,662.57 and runs through April 9, 2025. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order contract type. There is no set-aside designation for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKGUG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,917,052 tablets of the prescription drug TAGRISSO 40 MG. The contract, valued at $21,016.64, was awarded by the Defense Logistics Agency (DLA) on September 24, 2024, with a completion date of October 16, 2024. This is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and supplier of medical products to the federal government, including the military and other healthcare agencies. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for the provision of a wide range of pharmaceutical and medical supplies.

Generated 12/24/24, 9:31 AM